<code id='67402131B6'></code><style id='67402131B6'></style>
    • <acronym id='67402131B6'></acronym>
      <center id='67402131B6'><center id='67402131B6'><tfoot id='67402131B6'></tfoot></center><abbr id='67402131B6'><dir id='67402131B6'><tfoot id='67402131B6'></tfoot><noframes id='67402131B6'>

    • <optgroup id='67402131B6'><strike id='67402131B6'><sup id='67402131B6'></sup></strike><code id='67402131B6'></code></optgroup>
        1. <b id='67402131B6'><label id='67402131B6'><select id='67402131B6'><dt id='67402131B6'><span id='67402131B6'></span></dt></select></label></b><u id='67402131B6'></u>
          <i id='67402131B6'><strike id='67402131B6'><tt id='67402131B6'><pre id='67402131B6'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:52615
          Bristol Myers Squibb sign
          Courtesy Bristol Myers Squibb

          Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

          RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

          advertisement

          Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          Medicaid, Medicare dual
          Medicaid, Medicare dual

          TheSenatehassetitseyesonregulatinginsuranceplansforsomeofthemostvulnerablepatientsintheU.S.— the12.5

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          After a drawn out lobbying fight, ARPA

          Afteradrawn-outlobbyingfight,ARPA-Hchoseitsheadquarters:ahubandspokesmodel,withthreecentrallocations